SCHEMBL25975485

SCHEMBL25975485

CCNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)CCCCCN1C(=O)C=CC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.50
FAAH O00519 2/20 0.46
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
PSMB5 P28074 2/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA4 P43681 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25967838 1.00 AKT1 (0.50) AKT1FAAHHDAC3HDAC4HDAC1
SCHEMBL24835050 0.97 AKT1 (0.49) AKT1FAAHHDAC3HDAC4HDAC1
SCHEMBL25979696 0.92 AKT1 (0.50) AKT1FAAHHDAC3HDAC4HDAC1
SCHEMBL24320754 0.92 AKT1 (0.48) AKT1FAAHHDAC3HDAC4HDAC1
SCHEMBL22519634 0.91 AKT1 (0.49) AKT1FAAHHDAC3HDAC4HDAC1
SCHEMBL25967517 0.91 AKT1 (0.49) AKT1FAAHHDAC3HDAC4HDAC1
SCHEMBL23630030 0.91 AKT1 (0.48) AKT1HDAC3HDAC4HDAC1HDAC7
SCHEMBL23630027 0.91 AKT1 (0.48) AKT1HDAC3HDAC4HDAC1HDAC7
SCHEMBL25873361 0.91 AKT1 (0.48) AKT1HDAC3HDAC4HDAC1HDAC7
SCHEMBL20787950 0.91 FAAH (0.50) AKT1FAAHHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223318-A1 ANTITUMOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Duality Biologics (Suzhou) Co., Ltd. (CN) 2023-08-09 EP disclosed